Capricor Therapeutics (CAPR) EPS (Weighted Average and Diluted) Growth (3y) (2020 - 2026)
Capricor Therapeutics (CAPR) EPS (Weighted Average and Diluted) Growth (3y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
59.54% |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
22,777.33% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
1,857.10% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
41.33% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
14.33% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
-23.93% |
| Date | Value |
|---|
| Mar 31, 2026 |
-23.93% |
| Dec 31, 2025 |
-25.99% |
| Sep 30, 2025 |
-27.59% |
| Jun 30, 2025 |
-25.26% |
| Mar 31, 2025 |
-18.32% |
| Dec 31, 2024 |
24.93% |
| Sep 30, 2024 |
-30.75% |
| Jun 30, 2024 |
-18.56% |
| Mar 31, 2024 |
-10.46% |
| Dec 31, 2023 |
27.12% |
| Sep 30, 2023 |
-2.82% |
| Jun 30, 2023 |
-8.03% |
| Dec 31, 2021 |
-32.87% |
| Dec 31, 2020 |
-43.57% |
